DK563886A - THERAPEUTIC COMPOSITION - Google Patents

THERAPEUTIC COMPOSITION

Info

Publication number
DK563886A
DK563886A DK563886A DK563886A DK563886A DK 563886 A DK563886 A DK 563886A DK 563886 A DK563886 A DK 563886A DK 563886 A DK563886 A DK 563886A DK 563886 A DK563886 A DK 563886A
Authority
DK
Denmark
Prior art keywords
disturbances
composition
bleeding
well
patients suffering
Prior art date
Application number
DK563886A
Other languages
Danish (da)
Other versions
DK156699B (en
DK156699C (en
DK563886D0 (en
Inventor
Ulla Karin Elisabeth Hedner
Original Assignee
Novo Industri As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK544685A external-priority patent/DK544685D0/en
Priority claimed from DK459286A external-priority patent/DK459286D0/en
Application filed by Novo Industri As filed Critical Novo Industri As
Priority to DK563886A priority Critical patent/DK156699C/en
Publication of DK563886D0 publication Critical patent/DK563886D0/en
Publication of DK563886A publication Critical patent/DK563886A/en
Publication of DK156699B publication Critical patent/DK156699B/en
Application granted granted Critical
Publication of DK156699C publication Critical patent/DK156699C/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The patent describes a process for treating patients suffering from bleeding disturbances which are not due to coagulation factor defects or coagulation factor inhibitors, as well as a previously unknown composition for use in the treatment of bleeding disturbances. The process involves administering, to a patient, a composition which comprises an effective haemostatic quantity of factor VIIa and it is particularly effective when treating patients suffering from thrombocytopenia and von Willebrand's syndrome, as well as other blood platelet disturbances. A composition which is suitable for treating such bleeding disturbances comprises purified factor VIIa in a concentration of at least 25 μg/ml.
DK563886A 1985-11-26 1986-11-25 APPLICATION OF FACTOR VIIA FOR THE PREPARATION OF A THERAPEUTIC COMPOSITION FOR THE TREATMENT OF Bleeding disorders DK156699C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK563886A DK156699C (en) 1985-11-26 1986-11-25 APPLICATION OF FACTOR VIIA FOR THE PREPARATION OF A THERAPEUTIC COMPOSITION FOR THE TREATMENT OF Bleeding disorders

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DK544685A DK544685D0 (en) 1985-11-26 1985-11-26 THERAPEUTIC COMPOSITION
DK544685 1985-11-26
DK459286A DK459286D0 (en) 1986-09-26 1986-09-26 THERAPEUTIC COMPOSITION
DK459286 1986-09-26
DK563886A DK156699C (en) 1985-11-26 1986-11-25 APPLICATION OF FACTOR VIIA FOR THE PREPARATION OF A THERAPEUTIC COMPOSITION FOR THE TREATMENT OF Bleeding disorders
DK563886 1986-11-25

Publications (4)

Publication Number Publication Date
DK563886D0 DK563886D0 (en) 1986-11-25
DK563886A true DK563886A (en) 1987-05-27
DK156699B DK156699B (en) 1989-09-25
DK156699C DK156699C (en) 1990-03-05

Family

ID=27222001

Family Applications (1)

Application Number Title Priority Date Filing Date
DK563886A DK156699C (en) 1985-11-26 1986-11-25 APPLICATION OF FACTOR VIIA FOR THE PREPARATION OF A THERAPEUTIC COMPOSITION FOR THE TREATMENT OF Bleeding disorders

Country Status (1)

Country Link
DK (1) DK156699C (en)

Also Published As

Publication number Publication date
DK156699B (en) 1989-09-25
DK156699C (en) 1990-03-05
DK563886D0 (en) 1986-11-25

Similar Documents

Publication Publication Date Title
ATE66374T1 (en) PREPARATIONS AND METHODS FOR TREATMENT OF BLOOD DISORDERS.
ATE295176T1 (en) METHOD TO SUPPORT DIFFERENTIAL DIAGNOSIS AND TREATMENT OF AUTISTIC SYNDROME
DK0913156T3 (en) Use of activated protein C for the treatment of hypercoagulation conditions associated with sepsis
BG60253B1 (en) HUMAN TISSUE PLASMINOGENIC ACTIVATOR
DE69132688D1 (en) METHOD FOR TREATING AND PREVENTING TYPE-1 DIABETIS BY ORAL ADMINISTRATION OF INSULIN
NZ210275A (en) Modified hirudin and its antithrombin properties
DE1300150T1 (en) Prostaglandin derivatives used to treat glaucoma or hypertension
DE69230112T2 (en) ADVANCED DRUG DELIVERY SYSTEM AND METHOD FOR TREATING PSYCHIATRIC, NEUROLOGICAL AND OTHER DISEASES WITH CARBAMAZEPINE
DE69230046T2 (en) 2-bromomelatonin for the treatment of sleep disorders
ATE88899T1 (en) WOUND HEALING AND BONE REGENERATION.
EA199800690A1 (en) SUBSTITUTED N - [(AMINOIMINOMETHYL) PHENYLALKYL] AZHGETHROCYLAMIDE OF SULPHONIC ACIDS
EP0376251A3 (en) An anticoagulant substance obtained from urine
DE3685853D1 (en) AGENTS FOR THE TREATMENT OF BONE DISEASES.
ES2160643T3 (en) COMPOSITIONS CONTAINING G-CSF AND PROTEIN OF UNION TO TNF.
KR950703004A (en) INHIBITOR OF COLLAGEN-STIMULATED PLATELET AGGREGATION
NO913129L (en) NEW TROMBOLYTIC AGENT.
ATE80039T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING 2',3'-DIDEOXYCYTIDIN-2'-EN(2',3'-DIDEOXY-2',3'DIDEHYDROCYTIDIN) FOR THE TREATMENT OF PATIENTS INFECTED WITH RETROVIRUS.
DE69327314D1 (en) Compositions containing lipoprotein associated coagulation inhibitor (LACI) for the manufacture of a medicament for the treatment of acute or chronic inflammation
ATE126061T1 (en) USE OF LITHIUM FOR THE TREATMENT OR PROPHYLAXIS OF MOLLUSCUM CONTAGIUSUM.
JPS5932443B2 (en) Thrombin blocking substance, method for producing the same, and pharmaceutical composition for thrombin blocking containing the substance
ATE430578T1 (en) FACTOR VIII OR VON WILLEBRAND FACTOR FOR THE TREATMENT OF THROMBOPATHY-ASSOCIATED HEMORRHAGIC DISEASES
DK563886A (en) THERAPEUTIC COMPOSITION
ATE44750T1 (en) PROCESS FOR PREPARING AN ANTI-HEMOPHILIA FACTOR CONCENTRATE.
DE3650368D1 (en) Use of Depogen to treat restricted blood circulation.
UA7180C2 (en) DRUG FOR TREATMENT AND PREVENTION OF ATHEROGENIC DISLIPOPROTEINEMIA AND HYPERCOAGULATION SYNDROME

Legal Events

Date Code Title Description
PUP Patent expired